FDA stands by mifepri­s­tone safe­ty la­bel in fed­er­al court chal­lenge

The FDA is push­ing back against claims that its safe­ty re­stric­tions for the abor­tion pill mifepri­s­tone are “oner­ous and med­ical­ly un­nec­es­sary.”

In re­sponse to a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER